Charlotte's Web Holdings CWBHF
OTC CWBHF
$0.31 +0.02 (+6.21%)
At close: Aug 19, 2026 · 2:50 PM UTC

Charlotte's Web Holdings (CWBHF) Liabilities and Shareholders Equity (2020 - 2026)

Charlotte's Web Holdings (CWBHF) posted quarterly Liabilities and Shareholders Equity of $70.7 million for Q1 2026, down 34.56% year-over-year from $108.0 million in Q1 2025, and down 6.09% quarter-over-quarter from $75.3 million in Q4 2025.

Charlotte's Web Holdings (CWBHF) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

Charlotte's Web Holdings (CWBHF) has reported Liabilities and Shareholders Equity for 7 consecutive years, with $70.7 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Liabilities and Shareholders Equity fell 34.56% year-over-year to $70.7 million; the TTM figure through Mar 2026 stood at $315.5 million (down 32.99% YoY), while the FY2025 annual figure was $75.3 million, down 33.65% from the prior year.
  • Liabilities and Shareholders Equity slipped to $70.7 million in Q1 2026 per CWBHF's latest filing, from $75.3 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $187.6 million in Q4 2022 and bottomed at $70.7 million in Q1 2026.
  • Historically, Liabilities and Shareholders Equity has averaged $131.7 million across 5 years, with a median of $140.5 million in 2022.
  • Annual changes were most pronounced in 2023 — Liabilities and Shareholders Equity climbed 16.62% — and 2026, when it slumped 34.56%.
  • Charlotte's Web Holdings' Liabilities and Shareholders Equity stood at $187.6 million in 2022, then fell by 18.7% to $152.5 million in 2023, then retreated by 25.64% to $113.4 million in 2024, then tumbled by 33.65% to $75.3 million in 2025, then slipped by 6.09% to $70.7 million in 2026.
  • Business Quant data shows CWBHF's Liabilities and Shareholders Equity at $70.7 million in Q1 2026, $75.3 million in Q4 2025, and $81.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Haleon 43.94 Bn 42.97 Bn - 43.71 Bn
2 Teva Pharmaceutical Industries 42.95 Bn 39.30 Bn 2.15 Bn 39.86 Bn
3 Zoetis 31.58 Bn 29.90 Bn 1.05 Bn 15.08 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn 98.27 Bn
5 United Therapeutics 22.16 Bn 19.49 Bn 683.80 Mn 7.22 Bn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn 35.04 Bn
7 Neurocrine Biosciences 15.53 Bn 15.14 Bn 935.80 Mn 5.36 Bn
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn 13.56 Bn
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn - 6.18 Bn
10 Charlotte's Web Holdings 63.18 Mn 49.19 Mn 5.16 Mn 76.39 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 76.39 Mn
Mar 31, 2026 70.69 Mn
Dec 31, 2025 75.27 Mn
Sep 30, 2025 81.60 Mn
Jun 30, 2025 87.98 Mn
Mar 31, 2025 108.02 Mn
Dec 31, 2024 113.44 Mn
Sep 30, 2024 119.64 Mn
Jun 30, 2024 129.79 Mn
Mar 31, 2024 141.78 Mn
Dec 31, 2023 152.55 Mn
Sep 30, 2023 163.87 Mn
Jun 30, 2023 176.59 Mn
Mar 31, 2023 175.97 Mn
Dec 31, 2022 187.64 Mn
Sep 30, 2022 140.52 Mn
Jun 30, 2022 153.01 Mn
Mar 31, 2022 160.82 Mn
Dec 31, 2021 171.51 Mn
Dec 31, 2020 310.79 Mn